10-Q: Clorox Reports Mixed Results in Q2 2025, Impacted by Divestitures and Cyberattack Recovery

Clorox's second quarter of fiscal year 2025 saw a decrease in net sales but an increase in earnings per share, influenced by divestitures, cyberattack recovery, and cost-saving measures.

Summary

• Clorox's net sales decreased by 15% in the three months ended December 31, 2024, compared to the same period in 2023, totaling $1.686 billion.
• However, net sales increased by 2% for the six months ended December 31, 2024, reaching $3.448 billion.
• The company's gross profit was $738 million for the three months and $1.545 billion for the six months ended December 31, 2024.
• Diluted net earnings per share increased significantly, rising 105% to $1.54 for the quarter and 154% to $2.34 for the six-month period.
• The company experienced a loss on divestiture of $118 million related to the Better Health VMS business.
• Clorox also recorded insurance recoveries of $35 million related to the August 2023 cyberattack.
• The company's streamlined operating model is expected to generate ongoing cost savings.
• The company completed the divestiture of its Better Health VMS business on September 10, 2024.
• The company also completed the divestiture of its Argentina business on March 20, 2024.

Sentiment

Score: 6

Explanation: The document presents a mixed picture with positive earnings growth offset by sales declines and ongoing challenges. The company is recovering from past issues and implementing cost-saving measures, but faces a volatile operating environment.

Positives

• Diluted earnings per share saw a significant increase of 105% for the quarter and 154% for the six-month period.
• Gross margin improved to 43.8% for the quarter and 44.8% for the six-month period.
• The company received $35 million in insurance recoveries related to the cyberattack.
• The streamlined operating model is expected to generate ongoing cost savings.
• The company's financial position and liquidity remained strong as of December 31, 2024.

Negatives

• Net sales decreased by 15% in the three months ended December 31, 2024.
• The company recorded a $118 million loss on the divestiture of the Better Health VMS business.
• The company experienced a decrease in sales volume in the three months ended December 31, 2024.
• The company experienced higher manufacturing and logistics costs.

Risks

• The company continues to monitor macroeconomic conditions, including elevated interest rates and capital market volatility.
• There are ongoing risks of negative impacts from transportation, logistical, and supply constraints.
• The company faces potential risks from higher commodity costs for certain raw materials.
• The operating environment is expected to remain volatile and challenging for the remainder of fiscal year 2025.
• The company is exposed to risks related to the ongoing conflicts in the Middle East and Ukraine, and rising tensions between China and Taiwan.
• The company is exposed to risks related to potential shifts in U.S. and foreign trade, economic and other policies.
• The company is exposed to risks related to the implementation of a new enterprise resource planning (ERP) system.

Future Outlook

The company anticipates the operating environment will remain volatile and challenging for the remainder of fiscal year 2025, but will continue to invest in its brands, capabilities, and people to deliver consistent, profitable growth over time.

Management Comments

• The company is committed to evolving its portfolio to reduce volatility and accelerate sales growth.
• The company will continue to invest in its brands, capabilities and people to deliver consistent, profitable growth over time.
• The company believes it will have the funds necessary to support its shortand long-term liquidity and operating needs.

Industry Context

The company operates in the consumer and professional products industry, facing competition from other nationally advertised brands and private label brands. The company's performance is influenced by macroeconomic conditions, consumer spending, and supply chain dynamics.

Comparison to Industry Standards

• Clorox's gross margin of 44.8% for the six months ended December 31, 2024, is comparable to other large consumer goods companies such as Procter & Gamble (PG) which reported a gross margin of 50.9% in their most recent quarter, and Colgate-Palmolive (CL) which reported a gross margin of 58.5% in their most recent quarter.
• Clorox's net sales decrease of 15% in the three months ended December 31, 2024, is worse than the performance of some of its competitors, such as P&G which reported a 3% increase in net sales in their most recent quarter, and Colgate-Palmolive which reported a 5.5% increase in net sales in their most recent quarter.
• The company's recovery from the cyberattack and its cost-saving initiatives are similar to actions taken by other companies in the industry to improve profitability and operational efficiency.
• The company's divestiture of non-core businesses is a common strategy in the consumer goods industry to focus on core brands and improve margins.

Stakeholder Impact

• Shareholders will see increased earnings per share, but may be concerned about the decrease in net sales.
• Employees may be impacted by the ongoing implementation of the streamlined operating model.
• Customers may experience changes in product availability due to supply chain issues.
• Suppliers may be impacted by the company's supply chain financing program.

Next Steps

• The company will continue to monitor macroeconomic conditions and their impact on the business.
• The company will continue to invest in its brands, capabilities, and people.
• The company will continue to implement its streamlined operating model and digital capabilities and productivity enhancements investment.
• The company will purchase P&G's 20% interest in the Glad business in January 2026.

Key Dates

Keywords

Clorox, financial results, divestiture, cyberattack, net sales, earnings per share, gross margin, cost savings, restructuring, supply chain, macroeconomic conditions